NTSB Issues Recommendation A-14-095 to FAA Regarding Pilot Drug Use Study

The National Transportation Safety Board, identified by reference number DCA14SS003, has issued safety recommendation A-14-095 addressed to the Federal Aviation Administration. This directive requires the agency to conduct a detailed study aimed at assessing the prevalence of over-the-counter, prescription, and illicit drug use among flying pilots who are not involved in accidents. The findings from this group must then be compared with results obtained from pilots who have died from aviation accidents. The purpose of this comparative analysis is to assess the safety risks associated with using these various types of drugs while flying.